Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Central Retinal Vein Occlusion (CRVO)
Clinical trial NCT01976312 · COMPLETED
Trial details
- NCT number
- NCT01976312
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-12
- Primary completion
- 2016-03-14
- Enrollment
- 252
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.